Form 8-K - Current report:
SEC Accession No. 0001654954-18-010158
Filing Date
2018-09-13
Accepted
2018-09-13 17:23:17
Documents
5
Period of Report
2018-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vtgn8k_sep112018.htm 8-K 36241
2 MATERIAL CONTRACTS ex10-1.htm EX-10.1 191229
3 MATERIAL CONTRACTS ex10-2.htm EX-10.2 240123
4 PRESS RELEASE ex99-1.htm EX-99.1 29575
5 IMAGE vtgn.jpg GRAPHIC 6742
  Complete submission text file 0001654954-18-010158.txt   507890
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

EIN.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 181069553
SIC: 2834 Pharmaceutical Preparations